Beijing Hotgen Biotech Co. Ltd. Class ASSE: 688068

Announcement on Convening the Q3 2025 Performance Briefing

Nov 15, 2025 · Issued by Beijing Hotgen Biotech Co. Ltd. Class A via Shanghai Stock Exchange

Announcement on Convening the Q3 2025 Performance Briefing

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment